CRO Mass Spectroscopy Services

Global CRO Mass Spectroscopy Services Market to Reach US$2.2 Billion by 2030

The global market for CRO Mass Spectroscopy Services estimated at US$930.0 Million in the year 2024, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 15.7% over the analysis period 2024-2030. Proteomics Services, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Metabolomics Services segment is estimated at 14.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$253.4 Million While China is Forecast to Grow at 20.9% CAGR

The CRO Mass Spectroscopy Services market in the U.S. is estimated at US$253.4 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$486.6 Million by the year 2030 trailing a CAGR of 20.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.5% and 14.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.5% CAGR.

Global CRO Mass Spectroscopy Services Market – Key Trends & Drivers Summarized

Why Are CRO Mass Spectroscopy Services in High Demand? Exploring the Need for Advanced Analytical Testing

The global contract research organization (CRO) mass spectroscopy services market is expanding rapidly due to the increasing complexity of drug development, stringent regulatory requirements, and the growing demand for high-precision analytical testing in pharmaceutical and biotechnology industries. Mass spectrometry is a crucial technique for identifying chemical compounds, detecting impurities, and characterizing biomolecules with high sensitivity and accuracy. As biopharmaceutical companies focus on improving drug safety and efficacy, outsourcing analytical testing to CROs has become a cost-effective solution. The rise of personalized medicine, biosimilars, and complex biologics has further driven the demand for specialized mass spectrometry services.

Which Mass Spectroscopy Services Are Leading the CRO Market? A Breakdown of Key Segments

The CRO mass spectroscopy services market includes various specialized analytical techniques tailored for different research and regulatory needs. Liquid chromatography-mass spectrometry (LC-MS) is widely used for drug discovery, pharmacokinetics, and metabolomics studies. Gas chromatography-mass spectrometry (GC-MS) remains a key technique for environmental and forensic testing, as well as volatile compound analysis. High-resolution mass spectrometry (HRMS) and tandem mass spectrometry (MS/MS) are essential for proteomics and biomarker discovery. Additionally, mass spectrometry imaging (MSI) is gaining traction in biomedical research for tissue analysis and disease profiling. The integration of automation and AI-driven data analysis has further enhanced mass spectrometry capabilities, improving throughput and precision.

How Is Technology Transforming CRO Mass Spectrometry Services? The Role of AI, Automation & Real-Time Analysis

The CRO mass spectrometry industry is evolving with technological advancements in AI-driven data processing, automation, and real-time molecular analysis. AI-powered mass spectrometry software has improved spectral interpretation, reducing the time required for complex compound identification. The development of real-time mass spectrometry techniques, such as ambient ionization mass spectrometry, has enabled faster sample analysis in clinical and pharmaceutical applications. Additionally, automation in sample preparation and high-throughput screening has enhanced efficiency and scalability in CRO laboratories. Cloud-based data management solutions have also facilitated remote collaboration and regulatory compliance, ensuring seamless access to analytical results across global research teams.

What’s Driving the Growth of the CRO Mass Spectrometry Services Market? Key Market Influencers Explained

The growth in the CRO mass spectrometry services market is driven by increasing pharmaceutical R&D investments, rising regulatory scrutiny, and the demand for high-precision bioanalytical testing. The expansion of biologics and gene therapy research has created new opportunities for CROs specializing in mass spectrometry-based biomolecular analysis. Additionally, the growing need for quality control in food safety, environmental monitoring, and forensic science has broadened market applications. The shift toward contract-based research outsourcing has allowed pharmaceutical companies to streamline their drug development processes, further strengthening the CRO mass spectrometry sector. With continuous technological advancements and increasing analytical requirements, the market is expected to experience sustained growth in the coming years.

SCOPE OF STUDY:

The report analyzes the CRO Mass Spectroscopy Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Service Type (Proteomics Services, Metabolomics Services, Other Services); End-Use (Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -
  • 360biolabs
  • ABC Laboratories
  • Accurant Biotech
  • ACM Global Laboratories
  • Active Biomarkers
  • Alderley Analytical
  • Alliance Pharma
  • Allumiqs
  • Altasciences
  • Analytik Jena
  • BioAgilytix
  • Charles River Laboratories
  • CovalX
  • Creative Proteomics
  • Labcorp Drug Development
  • MS Bioworks
  • Novatia
  • Omics Solutions
  • PPD Laboratories
  • Waters Corporation

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
CRO Mass Spectroscopy Services – Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Demand for High-Precision Analytical Services Drives Growth in CRO Mass Spectrometry Services
Surge in Biopharmaceutical and Biotechnology Research Expands Addressable Market for Mass Spectrometry in Drug Development
Rising Complexity of Drug Discovery and Development Processes Strengthens Business Case for Advanced Mass Spectrometry Solutions
Technological Advancements in Mass Spectrometry Instrumentation Drive Market Innovation and Demand for Outsourced Services
Growing Focus on Personalized Medicine and Targeted Therapies Accelerates the Need for Advanced Mass Spectrometry in Clinical Trials
Expansion of Proteomics and Metabolomics Research Generates New Opportunities for CRO Mass Spectrometry Services
Increasing Investment in R&D by Pharmaceutical Companies Spreads Demand for Mass Spectrometry Services in Drug Discovery
The Integration of Mass Spectrometry with Other Analytical Techniques Expands Market Opportunity for Multi-Technique Research Solutions
The Rising Popularity of Biomarker Discovery Drives Accelerated Demand for Mass Spectrometry in Clinical and Translational Research
Advancements in Quantitative Mass Spectrometry and Data Analysis Strengthen the Business Case for Accurate, Reproducible Results
Increasing Demand for High-Throughput and Automation in Research Drives Growth in Mass Spectrometry Service Offerings
Regulatory Pressures for Enhanced Safety and Efficacy of Drugs Strengthens the Case for Mass Spectrometry in Compliance Testing
Rising Demand for Environmental and Food Safety Testing Expands Market for CRO Mass Spectrometry Services in Non-Pharma Sectors
The Growth of Contract Research Organizations (CROs) in Emerging Markets Expands the Global Reach of Mass Spectrometry Services
Focus on Reducing Drug Development Costs and Time-to-Market Drives Adoption of CRO Mass Spectrometry Services in Early-Stage Research
Increasing Complexity of Biologics and Biosimilars Development Propels Market Demand for Mass Spectrometry in Protein Analysis
The Integration of Artificial Intelligence and Machine Learning with Mass Spectrometry Services Generates New Analytical Capabilities
The Need for High-Quality and Comprehensive Data in Clinical Trials Propels Demand for Advanced Mass Spectrometry in Regulatory Submissions
Heightened Interest in Translational Medicine and Diagnostics Creates Opportunities for Mass Spectrometry in Disease Biomarker Research
The Rise in Outsourcing Analytical Services by Pharmaceutical Companies Expands Market for CRO Mass Spectrometry Service Providers
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World CRO Mass Spectroscopy Services Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for CRO Mass Spectroscopy Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for CRO Mass Spectroscopy Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Proteomics Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Proteomics Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for Proteomics Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Metabolomics Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Metabolomics Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Metabolomics Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Pharmaceutical & biopharmaceutical companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Pharmaceutical & biopharmaceutical companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Pharmaceutical & biopharmaceutical companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Medical device companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Medical device companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Medical device companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 22: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 23: USA Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 24: USA Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 25: USA 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 26: USA Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 27: USA Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 28: USA 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
CANADA
TABLE 29: Canada Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 30: Canada Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 31: Canada 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 32: Canada Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 33: Canada Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 34: Canada 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
JAPAN
CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 35: Japan Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 36: Japan Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 37: Japan 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 38: Japan Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 39: Japan Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 40: Japan 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
CHINA
CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 41: China Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 42: China Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 43: China 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 44: China Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 45: China Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 46: China 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
EUROPE
CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 47: Europe Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 48: Europe Historic Review for CRO Mass Spectroscopy Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 49: Europe 15-Year Perspective for CRO Mass Spectroscopy Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 51: Europe Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 52: Europe 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 53: Europe Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 54: Europe Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 55: Europe 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
FRANCE
CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 56: France Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 57: France Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 58: France 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 59: France Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 60: France Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 61: France 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
GERMANY
CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 62: Germany Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 63: Germany Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 64: Germany 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 65: Germany Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 66: Germany Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 67: Germany 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
ITALY
TABLE 68: Italy Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 69: Italy Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 70: Italy 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 71: Italy Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 72: Italy Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 73: Italy 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
UNITED KINGDOM
CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 74: UK Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 75: UK Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 76: UK 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 77: UK Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 78: UK Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 79: UK 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
SPAIN
TABLE 80: Spain Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 81: Spain Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 82: Spain 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 83: Spain Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 84: Spain Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 85: Spain 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
RUSSIA
TABLE 86: Russia Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 87: Russia Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 88: Russia 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 89: Russia Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 90: Russia Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 91: Russia 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 94: Rest of Europe 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 96: Rest of Europe Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 97: Rest of Europe 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
ASIA-PACIFIC
CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for CRO Mass Spectroscopy Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 100: Asia-Pacific 15-Year Perspective for CRO Mass Spectroscopy Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 103: Asia-Pacific 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 106: Asia-Pacific 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
AUSTRALIA
CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 107: Australia Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 108: Australia Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 109: Australia 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 110: Australia Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 111: Australia Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 112: Australia 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
INDIA
CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 113: India Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 114: India Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 115: India 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 116: India Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 117: India Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 118: India 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
SOUTH KOREA
TABLE 119: South Korea Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 120: South Korea Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 121: South Korea 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 122: South Korea Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 123: South Korea Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 124: South Korea 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 126: Rest of Asia-Pacific Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 127: Rest of Asia-Pacific 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 129: Rest of Asia-Pacific Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 130: Rest of Asia-Pacific 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
LATIN AMERICA
CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 131: Latin America Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 132: Latin America Historic Review for CRO Mass Spectroscopy Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 133: Latin America 15-Year Perspective for CRO Mass Spectroscopy Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
TABLE 134: Latin America Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 135: Latin America Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 136: Latin America 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 137: Latin America Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 138: Latin America Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 139: Latin America 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
ARGENTINA
TABLE 140: Argentina Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 141: Argentina Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 142: Argentina 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 143: Argentina Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 144: Argentina Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 145: Argentina 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
BRAZIL
TABLE 146: Brazil Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 147: Brazil Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 148: Brazil 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 149: Brazil Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 150: Brazil Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 151: Brazil 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
MEXICO
TABLE 152: Mexico Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 153: Mexico Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 154: Mexico 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 155: Mexico Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 156: Mexico Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 157: Mexico 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 159: Rest of Latin America Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 160: Rest of Latin America 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 162: Rest of Latin America Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 163: Rest of Latin America 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
MIDDLE EAST
CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 164: Middle East Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 165: Middle East Historic Review for CRO Mass Spectroscopy Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 166: Middle East 15-Year Perspective for CRO Mass Spectroscopy Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
TABLE 167: Middle East Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 168: Middle East Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 169: Middle East 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 170: Middle East Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 171: Middle East Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 172: Middle East 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
IRAN
TABLE 173: Iran Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 174: Iran Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 175: Iran 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 176: Iran Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 177: Iran Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 178: Iran 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
ISRAEL
TABLE 179: Israel Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 180: Israel Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 181: Israel 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 182: Israel Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 183: Israel Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 184: Israel 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
SAUDI ARABIA
TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 186: Saudi Arabia Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 187: Saudi Arabia 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 189: Saudi Arabia Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 190: Saudi Arabia 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 191: UAE Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 192: UAE Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 193: UAE 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 194: UAE Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 195: UAE Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 196: UAE 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 198: Rest of Middle East Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 199: Rest of Middle East 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 201: Rest of Middle East Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 202: Rest of Middle East 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
AFRICA
CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 203: Africa Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 204: Africa Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 205: Africa 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
TABLE 206: Africa Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 207: Africa Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 208: Africa 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings